Compare RGS & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RGS | DRIO |
|---|---|---|
| Founded | 1922 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 72.0M | 60.6M |
| IPO Year | 1994 | 2013 |
| Metric | RGS | DRIO |
|---|---|---|
| Price | $28.00 | $7.62 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $35.00 |
| AVG Volume (30 Days) | ★ 7.2K | 6.0K |
| Earning Date | 05-06-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 20.24 | ★ 1559.02 |
| EPS | 0.89 | ★ 1.25 |
| Revenue | ★ $210,134,000.00 | $7,394,000.00 |
| Revenue This Year | N/A | $20.27 |
| Revenue Next Year | N/A | $47.58 |
| P/E Ratio | $31.85 | ★ $6.18 |
| Revenue Growth | 3.52 | ★ 43.02 |
| 52 Week Low | $18.23 | $0.38 |
| 52 Week High | $31.50 | $17.74 |
| Indicator | RGS | DRIO |
|---|---|---|
| Relative Strength Index (RSI) | 51.90 | 46.53 |
| Support Level | $25.95 | $7.29 |
| Resistance Level | $28.51 | $9.46 |
| Average True Range (ATR) | 1.03 | 0.45 |
| MACD | -0.07 | -0.05 |
| Stochastic Oscillator | 56.88 | 25.47 |
Regis Corporation owns, franchises, and operates beauty salons in North America and the U.K., serving mainly price-conscious customers. Its salons, located mostly in strip malls, shopping centers, and Walmart stores, offer services like haircutting, styling, shampooing, conditioning, and hair coloring, along with hair care and beauty products. The company's primary brands include Supercuts, SmartStyle, and Cost Cutters. Regis generates the majority of its revenue from these mass-market locations and reports operations in two segments: franchise and company-owned, with services making up about 94% of company-owned salon sales.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.